Abstracts

HIV TRENDS AMONG THE AMERICAN INDIAN/ALASKA NATIVES, 2014-2018

HIV diagnosis rates among American Indian/Alaska Natives (AI/AN) are higher than rates in whites and some minorities such as Asians. We evaluated HIV trends in diagnoses and mortality among AI/AN between 2014-2018. We analyzed HIV surveillance data reported to CDC by state and local health departments focusing on the AI/AN population from 2014-2018. We focused…

LOWER UPTAKE OF DOLUTEGRAVIR AMONG WOMEN OF REPRODUCTIVE POTENTIAL VS MEN—KENYA

The transition to dolutegravir (DTG)-containing combination antiretroviral therapy (cART) is expected to benefit population health, but its use among women of reproductive potential-the largest group affected by the HIV epidemic in sub-Saharan Africa-has been controversial because of a potential association between DTG use at conception and neural tube defects. In July 2019, the World Health…

RCT OF AN ONLINE MENTAL HEALTH INTERVENTION AMONG OLDER PLWH DURING COVID-19 PANDEMIC

Older adults (?50 y) living with HIV (OALWH) may experience elevated levels of depression, anxiety, and loneliness. Online mindfulness lessons have the potential to ameliorate these problems and enhance access, especially during the COVID-19 pandemic. The objective of this randomized controlled trial was to determine the effectiveness of online mindfulness lessons in reducing feelings of…

NEXT-GENERATION ISLATRAVIR IMPLANTS PROJECTED TO PROVIDE YEARLY HIV PROPHYLAXIS

Preexposure prophylaxis (PrEP) with antiretroviral drugs has demonstrated efficacy in reducing new HIV infections, although efficacy is tightly linked to good adherence, especially in women. Islatravir (MK-8591) is a nucleoside reverse transcriptase translocation inhibitor with high potency and long t1/2, currently in development for PrEP as an oral monthly pill. In addition, prototype islatravir implants…

RANDOMIZED TRIAL OF RESISTANCE TESTING FOR VIROLOGIC FAILURE IN SUB-SAHARAN AFRICA

Genotypic resistance testing (GRT) is recommended after virologic failure in resource-rich settings. By contrast, guidelines in sub-Saharan Africa promote adherence support and repeat virologic monitoring, in the absence of GRT, to guide treatment. We conducted an open-label, randomized controlled trial to assess whether GRT improved virologic suppression after first-line antiretroviral therapy (ART) failure in sub-Saharan…

SHORT-COURSE ALENDRONATE FOR THE PREVENTION OF ART-ASSOCIATED BONE LOSS

Antiretroviral therapy (ART) initiation encompasses a period of accelerated BMD loss in people with HIV (PWH). The Alendronate for the Prevention of ART associated bone loss (APART) study aimed to evaluate if short-term use of the oral, generic bisphosphonate alendronate (ALN) could prevent BMD loss at ART initiation In this multisite, double blinded, placebo-controlled phase…

PREVENTION OF CARDIOVASCULAR DISEASE IN PERSONS WITH AND WITHOUT HIV

With higher risk of cardiovascular disease (CVD) in persons with HIV (PWH), management of hypertension, dyslipidemia, and diabetes mellitus is crucial. Here, we evaluate the extent to which PWH have successfully managed these conditions and their influence on CVD risk. Cohort study of adult (?18 years) PWH and 20:1 age-, sex-, race/ethnicity-matched persons without HIV…